The Ozempic bone loss risk is something most patients never hear about at the pharmacy counter. A new study analyzing data from nearly 150,000 adults found a modest but notable increase in osteoporosis among people taking GLP-1 medications like Ozempic and Wegovy compared to those who weren’t. The cardiovascular and metabolic benefits of these drugs are well-documented — but if you’re on one long-term, it’s worth understanding what the science says about your bones.

What the Study Found

The research team looked at health records from roughly 150,000 adults with obesity and Type 2 diabetes over a five-year period. Among patients using GLP-1 receptor agonists (like semaglutide, the active ingredient in both Ozempic and Wegovy), about 4% developed osteoporosis. In the group that didn’t take these medications, the rate was just over 3%.

That difference works out to approximately a one-third increase in relative risk. The study also found a slightly higher rate of gout in the GLP-1 group. Researchers were careful to note that the overall risk remains low — but the signal is consistent enough that they believe it warrants clinical attention, particularly for patients who are already at higher risk for bone-related conditions.

Why Might GLP-1 Drugs Affect Bone Health?

Understanding the Ozempic bone loss risk starts with looking at what rapid weight loss does to the skeleton. Scientists haven’t pinned down a single cause yet, but there are a few plausible explanations worth knowing about.

Rapid Weight Loss Changes How Bones Are Stressed

Your skeleton is constantly remodeling itself in response to mechanical load — the physical pressure of supporting your body weight. When you lose weight quickly, that load decreases, and bone formation can slow as a result. This isn’t unique to GLP-1 drugs. It’s a known concern with bariatric surgery too, where aggressive caloric restriction is associated with measurable bone density loss over time.

Appetite Suppression Can Reduce Key Nutrients

GLP-1 medications work partly by reducing appetite. That’s great for weight management, but it also means many patients are eating less overall, which can translate to lower intake of calcium and vitamin D — two nutrients that are essential for maintaining bone density. Without deliberate supplementation, this nutritional gap can quietly compound over months and years.

The Gout Connection

The slight uptick in gout cases likely ties back to rapid fat loss. When the body breaks down fat tissue quickly, uric acid levels can spike temporarily. For patients who already have elevated uric acid or a family history of gout, this metabolic shift can trigger flare-ups. It’s a known phenomenon with aggressive weight loss programs in general, and something your doctor should be monitoring if you’re on a GLP-1 medication.

Should You Stop Taking Ozempic or Wegovy?

Not based on this study alone. For most patients with obesity and Type 2 diabetes, the cardiovascular and metabolic benefits of GLP-1 medications are well-documented and significant. The SELECT trial, published in the New England Journal of Medicine, showed semaglutide reduced major cardiovascular events by 20% in high-risk patients. That’s a substantial benefit.

What this research does argue for is more comprehensive monitoring — not panic. The goal is to get the benefits of these medications while proactively protecting the parts of your health that might be vulnerable.

What You Can Do to Protect Your Bones

If you’re currently on a GLP-1 medication, here are some concrete, evidence-based steps worth discussing with your doctor:

Get a baseline bone density scan (DEXA) — especially if you’re over 50, postmenopausal, or have a family history of osteoporosis. The National Osteoporosis Foundation recommends screening for women at 65 and men at 70, but earlier if risk factors are present.
Supplement calcium and vitamin D consistently — most adults need 1,000–1,200 mg of calcium daily and at least 600–800 IU of vitamin D. If your appetite is suppressed from medication, diet alone may not be enough.
Incorporate weight-bearing exercise — walking, resistance training, and strength work all help maintain bone density during weight loss. The CDC recommends at least 150 minutes of moderate activity per week for adults.
Ask your doctor to monitor uric acid levels — particularly if you have a history of gout or kidney stones.
Don’t skip follow-up appointments — long-term medication management requires ongoing lab work and clinical check-ins, not just an annual prescription renewal.

For families in Murphy, Plano, Wylie, and surrounding Collin County communities, Dr. Hina Zaman at Family Care USA offers comprehensive chronic disease management that includes monitoring for exactly these kinds of secondary effects. If you’re on a GLP-1 medication and haven’t had a recent bone health conversation with your provider, it might be time to schedule one.

A Note for South Asian Patients

It’s worth noting that South Asian adults — including Pakistani, Indian, and Bangladeshi communities — already face elevated baseline risk for both Type 2 diabetes and vitamin D deficiency, partly due to dietary patterns and reduced sun exposure in indoor-heavy lifestyles. If you’re from this background and on a GLP-1 drug, the conversation about bone health monitoring is especially relevant. Your provider can help you identify whether supplementation and screening should happen sooner rather than later.

Frequently Asked Questions

Does Ozempic cause osteoporosis?

A 2025 study found a modest increase in osteoporosis risk among GLP-1 users, roughly a one-third increase in relative terms. The absolute risk remains low, but patients on long-term GLP-1 therapy should discuss bone density monitoring with their doctor, particularly if other risk factors are present.

Can weight loss medications cause gout?

Rapid weight loss can temporarily raise uric acid levels, which may trigger gout flares in susceptible individuals. This was observed at slightly higher rates among GLP-1 users in the study. If you have a history of gout, let your doctor know before starting or continuing these medications.

Should I take calcium supplements while on Ozempic or Wegovy?

Because GLP-1 medications reduce appetite, many patients unintentionally reduce their intake of calcium and vitamin D. Most adults benefit from 1,000–1,200 mg of calcium and 600–800 IU of vitamin D daily. Ask your doctor whether supplementation is appropriate for your situation.

How do GLP-1 drugs affect bone density?

The mechanism isn’t fully established, but researchers believe rapid weight loss reduces the mechanical load on bones, potentially slowing bone formation. Reduced nutrient intake from appetite suppression is also a contributing factor. Weight-bearing exercise and adequate calcium and vitamin D intake can help offset this.

Is it safe to keep taking Ozempic if I’m worried about my bones?

For most patients, the metabolic and cardiovascular benefits of GLP-1 medications outweigh the modest bone risk. The key is not avoiding the medication but managing it with proper monitoring. Talk to your family doctor about a bone density scan and a nutrition plan that supports your skeletal health throughout treatment.

Resources

This article is for informational purposes only and does not constitute medical advice. Always consult your physician before making any changes to your treatment plan.

Bone Density Bone Loss GLP-1 GLP-1 Weight Loss Medication Osteoporosis Ozempic

Does Ozempic Cause Bone Loss? New Research Raises Questions About GLP-1 Drugs